India Ratings Affirms Credit Rating for Ipca Laboratories' Commercial Paper and Bank Facilities
India Ratings & Research (A Fitch Group Company) has affirmed the credit ratings for several key financial instruments issued by Ipca Laboratories Ltd., including commercial paper and bank loan facilities.The rating affirmation covers Ipca’s working capital limit, long-term loans, and commercial paper issuances. The review determined that the company maintained its standing across these debt instruments.
For Commercial Paper, rated by India Ratings,the instrument has a maturity date of up to 365 days and was issued in a size of INR 500 million, receiving an IND A1+ rating with an Affirmed status.
In addition, the ratings for Bank Loan Facilities were affirmed. The facilities are valued at INR 22481.10, which is a reduction from the previous amount of INR 25937.30. Ratings assigned to the bank loan facilities include IND AA+/ Stable and IND A1+, with an Affirmed action status.
The key financial details regarding the rated instruments are summarized in the table below:
| Instrument Type | Maturity Date | Size of Issue (Million) | Rating Assigned alongwith Outlook/Watch | Rating Action |
|---|---|---|---|---|
| Commercial Paper | Upto 365 days | INR 500 | IND A1+ | Affirmed |
| Bank Loan Facilities | N/A | INR 22481.10 | IND AA+/ Stable / IND A1+ | Affirmed |
IPCALAB Stock Price Movement
As of 12:20 PM, shares of IPCA Laboratories Limited are shedding value in live trading, dipping by 0.35% and currently residing at ₹1776.20. The pharmaceutical stock moves on a volume of 41,128 shares as it continues to navigate the active market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.